Skip to main content
C

Clinrol

Clinrol utilizes AI-driven algorithms to match patients with suitable clinical trials based on their medical conditions, while providing sponsors with targeted patient recruitment services. This approach addresses the significant challenge of patient enrollment, which contributes to the failure of over 80% of clinical trials due to missed deadlines.

Singapore, SingaporeFounded 20202500+ followers
Updated 8 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Patient enrollment is a major bottleneck in clinical trials, with many trials failing or experiencing delays due to difficulties in finding suitable participants. Traditional recruitment methods are often inefficient and costly, leading to missed deadlines and increased development expenses.

Solution

Clinrol leverages AI algorithms to streamline patient matching and recruitment for clinical trials. The platform analyzes patient data and trial criteria to identify optimal matches, connecting patients with relevant studies and enabling sponsors to efficiently find qualified participants. By improving the speed and accuracy of patient enrollment, Clinrol aims to reduce trial failures and accelerate the development of new therapies.

Target Audience

Clinrol's primary users are clinical trial sponsors, researchers, and patients seeking to participate in clinical trials.

Features

  • AI-powered patient-trial matching based on medical conditions and trial requirements
  • Extensive database of active clinical trials worldwide
  • Personalized alerts and updates on matching studies for patients
  • Streamlined platform for sponsors to claim clinical trials and connect with patients
  • Tools for sponsors to target and recruit specific patient populations
This profile is AI-generated and may contain inaccuracies.